Dose- and time-dependent oval cell reaction in acetaminophen-lnduced murine liver injury

Hepatology

Volumn 41, Issue 6, 2005, Pages 1252-1261

  Kofman, Alexander V ^a   Morgan, Glyn ^b   Kirschenbaum, Adam ^a   Osbeck, Jon ^a   Hussain, Mehboob ^a   Swenson, Scott ^a   Theise, Neil D ^a,c,d  

^a Liver and Stem Cell Research Laboratory   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; PARACETAMOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DENSITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE TIME EFFECT RELATION; DRUG INDUCED DISEASE; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INJURY SCALE; LIVER CELL; LIVER INJURY; MOUSE; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STEM CELL;

ACETAMINOPHEN; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IMMUNOLOGIC TECHNIQUES; KERATINS; LIVER; LIVER DISEASES; MICE; MICE, INBRED C57BL; STEM CELLS; TIME FACTORS;

EID: 20044374202     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20696     Document Type: Article

References (38)

1. Bustos M, Sangro B, Alzuguren P, Gil AG, Ruiz J, Beraza N, et al. Liver damage using suicide genes: a model for oval cell activation. Am J Pathol 2000;157:549-559.
2. Fausto N, Campbell JS. The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 2003;120:117-130.
3. Forbes S, Vig P, Poulsom R, Thomas H, Alison M. Hepatic stem cells. J Pathol 2002;197:510-518.
4. Guha C, Sharma A, Gupta S, Alfieri A, Gorla GR, Gagandeep S, et al. Amelioration of radiation-induced liver damage in partially hepatectomized rats by hepatocyte transplantation. Cancer Res 1999;59:5871-5874.
5. Shafritz DA, Dabeva MD. Liver stem cells and model systems for liver repopulation. J Hepatol 2002;36:552-564.
6. Sell S. The role of progenitor cells in repair of liver injury and in liver transplantation. Wound Repair Regen 2001;9:467-482.
7. Qiu Y, Benet LZ, Burlingame AL. Identification of the hepatic protein targets of reactive metabolites of acetaminophen in vivo in mice using two-dimensional gel electrophoresis and mass spectrometry. J Biol Chem 1998;273:17940-17953.
8. Ishida Y, Kondo T, Ohshima T, Fujiwara H, Iwakura Y, Mukaida N. A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J 2002;16:1227-1236.
9. Ito Y, Abril ER, Bethea NW, McCuskey RS. Role of nitric oxide in hepatic microvascular injury elicited by acetaminophen in mice. Am J Physiol Gastrointest Liver Physiol 2004;286:G60-G67.
10. Ren X, Carpenter A, Hogaboam C, Colletti L. Mitogenic properties of endogenous and pharmacological doses of macrophage inflammatory protein-2 after 70% hepatectomy in the mouse. Am J Pathol 2003;163:563-570.
11. Pagan E, Wannan G. Reducing paracetamol overdoses. BMJ 1996;313:1417-1418.
12. Makin A, Williams R. The current management of paracetamol overdosage. Br J Clin Pract 1994;48:144-148.
13. Schiodt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban county hospital. N Engl J Med 1997;337:1112-1117.
14. Waters E, Wang JH, Redmond HP, Wu QD, Kay E, Bouchier-Hayes D. Role of taurine in preventing acetaminophen-induced hepatic injury in the rat. Am J Physiol Gastrointest Liver Physiol 2001;280:G1274-G1279.
15. Ito Y, Bethea NW, Abril ER, McCuskey RS. Early hepatic microvascular injury in response to acetaminophen toxicity. Microcirculation 2003;10:391-400.
16. Lee JH, Rim HJ, Sell S. Heterogeneity of the "oval-cell" response in the hamster liver during cholangiocarcinogenesis following Clonorchis sinensis infection and dimethylnitrosamine treatment. J Hepatol 1997;26:1313-1323.
17. Libbrecht L, Roskams T. Hepatic progenitor cells in human liver diseases. Semin Cell Dev Biol 2002;13:389-396.
18. Lowes KN, Brennan BA, Yeoh GC, Olynyk JK. Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am J Pathol 1999;154:537-541.
19. Roskams TA, Libbrecht L, Desmet VJ. Progenitor cells in diseased human liver. Semin Liver Dis 2003;23:385-396.
20. Wang X, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, Grompe M. The origin and liver repopulating capacity of murine oval cells. Proc Natl Acad Sci U S A 2003;100(Suppl 1):11881-11888.
21. Libbrecht L, De Vos R, Cassiman D, Desmet V, Aerts R, Roskams T. Hepatic progenitor cells in hepatocellular adenomas. Am J Surg Pathol 2001;25:1388-1396.
22. Engelhardt NV, Factor VM, Medvinsky AL, Baranov VN, Lazareva MN, Poltoranina VS. Common antigen of oval and biliary epithelial cells (A6) is a differentiation marker of epithelial and erythroid cell lineages in early development of the mouse. Differentiation 1993;55:19-26.
23. Factor VM, Radaeva SA, Thorgeirsson SS. Origin and fate of oval cells in dipin-induced hepatocarcinogenesis in the mouse. Am J Pathol 1994;145:409-422.
24. Falkowski O, An HJ, Ianus IA, Chiriboga L, Yee H, West AB, et al. Regeneration of hepatocyte 'buds' in cirrhosis from intrabiliary stem cells. J Hepatol 2003;39:357-364.
25. Theise ND, Saxena R, Portmann BC, Thung SN, Yee H, Chiriboga L, et al. The canals of Hering and hepatic stem cells in humans. HEPATOLOGY 1999;30:1425-1433.
26. Faktor VM, Engel'gardt NV, Iazova AK, Lazareva MN, Poltoranina VS, Rudinskaia TD. [Common antigens of oval cells and cholangiocytes in the mouse. Their detection by using monoclonal antibodies]. Ontogenez 1990;21:625-632.
27. Tan J, Hytiroglou P, Wieczorek R, Park YN, Thung SN, Arias B, et al. Immunohistochemical evidence for hepatic progenitor cells in liver diseases. Liver 2002;22:365-373.
28. Engelhardt NV, Factor VM, Yasova AK, Poltoranina VS, Baranov VN, Lasareva MN. Common antigens of mouse oval and biliary epithelial cells: expression on newly formed hepatocytes. Differentiation 1990;45:29-37.
29. Muldrew KL, James LP, Coop L, McCullough SS, Hendrickson HP, Hinson JA, et al. Determination of acetaminophen-protein adducts in mouse liver and serum and human serum after hepatotoxic doses of acetaminophen using high-performance liquid chromatography with electrochemical detection. Drug Metab Dispos 2002;30:446-451.
30. Bartolone JB, Cohen SD, Khairallah EA. Immunohistochemical localization of acetaminophen-bound liver proteins. Fundam Appl Toxicol 1989;13:859-862.
31. Ruepp SU, Tonge RP, Shaw J, Wallis N, Pognan F. Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. Toxicol Sci 2002;65:135-150.
32. Rosenberg D, Ilic Z, Yin L, Sell S. Proliferation of hepatic lineage cells of normal C57BL and interleukin-6 knockout mice after cocaine-induced periportal injury. HEPATOLOGY 2000;31:948-955.
33. Baumann U, Crosby HA, Ramani P, Kelly DA, Strain AJ. Expression of the stem cell factor receptor c-kit in normal and diseased pediatric liver: identification of a human hepatic progenitor cell? HEPATOLOGY 1999;30:112-117.
34. Simpson K, Hogaboam CM, Kunkel SL, Harrison DJ, Bone-Larson C, Lukacs NW. Stem cell factor attenuates liver damage in a murine model of acetaminophen-induced hepatic injury. Lab Invest 2003;83:199-206.
35. Lowes KN, Croager EJ, Olynyk JK, Abraham LJ, Yeoh GC. Oval cell-mediated liver regeneration: role of cytokines and growth factors. J Gastroenterol Hepatol 2003;18:4-12.
36. Van Eyken P, Sciot R, Desmet V. Intrahepatic bile duct development in the rat: a cytokeratin-immunohistochemical study. Lab Invest 1988;59:52-59.
37. Roskams TA, Theise ND, Balabaud C, Bhagat G, Bhathal PS, Bioulac-Sage P, et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. HEPATOLOGY 2004;39:1739-1745.
38. Cassiman D, Libbrecht L, Sinelli N, Desmet V, Denef C, Roskams T. The vagal nerve stimulates activation of the hepatic progenitor cell compartment via muscarinic acetylcholine receptor type 3. Am J Pathol 2002;161:521-530.